Investors Love Lam Research Stock - Shorting OTM Puts in Huge, Unusual Volume
Bởi Maksym Misichenko · Yahoo Finance ·
Bởi Maksym Misichenko · Yahoo Finance ·
Các tác nhân AI nghĩ gì về tin tức này
The panel largely agrees that while LRCX's strong FCF growth and unusual put selling might suggest bullish sentiment, the cyclical nature of the semiconductor industry, potential margin compression, and customer concentration risk warrant caution. The high FCF margin may not be sustainable, and any normalization of hyperscaler budgets could lead to a re-rating of the stock.
Rủi ro: The cyclical nature of the semiconductor industry and potential margin compression.
Cơ hội: Potential for high FCF growth if AI-driven capex continues and margins remain strong.
Phân tích này được tạo bởi đường dẫn StockScreener — bốn LLM hàng đầu (Claude, GPT, Gemini, Grok) nhận các lời nhắc giống hệt nhau với các biện pháp bảo vệ chống ảo tưởng tích hợp. Đọc phương pháp →
Investors have pushed Lam Research Corp (LRCX) stock sky-high as its free cash flow and semiconductor equipment revenue surge. A Barchart report shows investors piling into out-of-the-money LRCX put options.
LRCX is down today at $316.41, off 2.0% today, but it's still up 60% since the end of March (i.e., $199.93 on March 30).
Investors are shorting out-of-the-money (OTM) Lam Research Corp (LRCX) put options to set a lower buy-in point and earn a 9% 3-month yield. This can be seen in a Barchart report that shows a 60x normal volume for an out-of-the-money LRCX put option.
The $290 LRCX put option expiring on Aug. 21, i.e., 8.34% below today's price (i.e., “out-of-the-money”), has a midpoint premium of $26.30. This put strike price has traded over 15,000 contracts traded today. That is 60 times the prior number of puts outstanding, a massive, unusual trading volume.
The Barchart Unusual Stock Options Activity Report today shows this massive trading volume in one put option contract. It seems to imply that some institutional investors are willing to buy LRCX at $290.00 and receive a huge income yield in return.
For example, one put contract shorted at $290.00 (i.e., an order to "Sell to Open) requires the investors to post collateral of $29,000. But, in return, the investor's account immediately receives $2,630. So, the short-put yield is:
$2,630 / $29,000 = 0.090689 = 9.0689% for the next 86 days (almost 3 months)
Moreover, the investor has a low breakeven point, even if LRCX falls 8.34% to $290.00:
$290.00 - $26.30 = $263.70
That is over 16.6% below today's LRCX stock price. In other words, the investor has a much lower potential buy-in. Meanwhile, their expected return is over 9% if LRCX stays over $290.00 for the next 86 days.
That is the same as buying LRCX and seeing the stock rise to $345 per share (i.e., +9%). In other words, these short-put investors are very bullish on LRCX.
Buyers of these puts must believe that LRCX will fall by over 16.6% for these puts to have any intrinsic value. That is a huge premium to pay to see a stock fall so much. This makes it more likely that the initiators of these put contracts were short-sellers bullish on LRCX stock. Let's look at why.
Strong Free Cash Flow Projections
Lam Research Corp., which makes semiconductor processing equipment and is benefiting from huge AI-related capex and investments by hyperscalers, reported that fiscal Q3 revenue rose 9.29% on a Q/Q basis (they don't even bother reporting the Y/Y numbers).
As a result, its revenue growth run rate could be over 36.1% (before compounding) over the next year. However, analysts are projecting a 32% FY revenue gain for the year ending June 30, 2027 (see below).
Moreover, diluted EPS was up 15.74% Q/Q, implying an annual run rate of 63% before compounding.
However, its free cash flow (FCF) fell 33.6% Q/Q to $809.82 million and -20.7% Y/Y. This was due to lower operating cash flow and higher capex. Nevertheless, its trailing 12-month (TTM) FCF was up 38% Y/Y to $6 billion (according to Stock Analysis). Moreover, its TTM FCF margin rose to 38.13% from 34.89% last quarter.
Based on analysts' revenue projections, FCF could surge next year. For example, analysts now forecast a 31.6% increase in FY 2027 revenue to $30.51 billion, up from $23.18 billion expected this fiscal year ending June 30, 2026.
So, if Lam Research can keep its TTM 38% FCF margin next year, FCF should rise to $11.6 billion (i.e., $30.51b x 0.381). That is 93% higher than the $6 billion over its most recent TTM period.
As a result, LRCX could be worth significantly more.
What LRCX Could Be Worth
Right now, Yahoo! Finance says Lam Research has a market capitalization of $398.5 billion. That implies that its TTM FCF of $6 billion represents a FCF yield of 1.50%:
$6b / $398.5 = 0.015 = 1.50% FCF yield
As a result, if we assume that the market values its expected FCF of $11.6 billion with the same yield, its market value could surge to $773 billion:
$11.6b / 0.015 = $773.33 billion
In other words, LRCX could see a huge 94% increase in the stock price:
$316.41 x 1.94 = $613.84 price target
That could be why investors have been pushing LRCX so high. And it also explains why investors are shorting out-of-the-money puts.
After all, if the short-sellers could repeat this 9.06% yield every 3 months for a year, they stand to make over 36.2%. That would be the equivalent of a price target of $431 per share.
That is lower than the $614 price target above, but shows why investors are bullish on LRCX stock.
On the date of publication, Mark R. Hake, CFA did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Bốn mô hình AI hàng đầu thảo luận bài viết này
"LRCX's 38% FCF margins and 94% upside thesis assume sustained AI-driven growth that cyclical capex patterns make improbable."
The article frames heavy shorting of the Aug 21 $290 puts as a bullish signal equivalent to owning the stock at a 9% quarterly yield with a $263.70 breakeven. Yet Lam's TTM 38% FCF margin and assumed 31.6% revenue growth to $30.5B in FY27 ignore the equipment sector's history of sharp capex swings once hyperscaler budgets normalize. At 1.5% FCF yield on $398B market cap the valuation already embeds aggressive growth; any margin compression or order pushouts would rapidly re-rate the multiple. The 60x volume in one strike may reflect hedging rather than outright conviction.
Semiconductor equipment orders have historically decoupled from AI hype within 12-18 months, and peers like ASML have already flagged softening demand outside leading-edge nodes.
"The article extrapolates a single quarter of strong FCF growth into a 94% upside scenario while ignoring that semiconductor equipment is cyclical, customer concentration is extreme, and a 1.5% FCF yield is unsustainably low for a capex-dependent business vulnerable to AI spending pullback."
The article conflates two separate bullish signals—strong FCF growth and unusual put selling—but conflates them dangerously. Yes, LRCX's TTM FCF is up 38% YoY to $6B, and the 38% FCF margin is impressive. But the Q3 sequential FCF *fell* 33.6%, which the article buries. The $290 put volume is real, but the article's interpretation—that short-sellers are 'bullish'—is backwards. Selling OTM puts is a bullish *income strategy*, not a short-seller's play. More critically: the $614 price target assumes the market maintains a 1.5% FCF yield *in perpetuity* while revenue grows 32% annually. That's historically low for semiconductor equipment (cyclical, capex-dependent). The article ignores: (1) semiconductor cycles, (2) customer concentration risk (hyperscalers), (3) whether 38% FCF margins are sustainable, and (4) valuation mean reversion.
If AI capex truly sustains at hyperscaler levels through 2027 and LRCX maintains 38% FCF margins, the $11.6B FCF projection is reasonable—and even a 1.5% yield (implying 66x FCF multiple) could hold if the market reprices LRCX as a secular growth story rather than cyclical equipment maker.
"The 9% quarterly yield on short puts is a tactical income play that masks significant underlying volatility risks and potential FCF margin compression in the cyclical semiconductor equipment sector."
The massive volume in $290 strike puts suggests institutional 'income harvesting' rather than pure directional conviction. While the article projects a 94% upside by 2027, this assumes a constant 1.5% FCF yield, which is historically aggressive for cyclical semiconductor equipment makers. Lam Research (LRCX) is currently benefiting from AI-driven capex, but the reported FCF decline (-33.6% Q/Q) is a red flag that the article glosses over. If the cyclical nature of wafer fab equipment spending hits a plateau, that 38% FCF margin will compress rapidly. Investors selling these puts are essentially betting on continued high-multiple expansion, ignoring the potential for a cyclical correction in 2025.
The 'unusual' put volume could represent large-scale hedging by institutional holders protecting gains, rather than just bullish income generation, suggesting a potential breakdown in the current momentum.
"The article's optimistic price target rests on fragile assumptions about FCF margins and AI-driven demand, and the unusual put activity is more likely hedging than a durable re-rating."
Framing LRCX through OTM put volume reads as a bullish bet, but the piece leans on optimistic FCF margins and a 31.6% revenue lift that aren’t guaranteed. The math relies on a 38% trailing FCF margin persisting into next year, which is aggressive given AI-capex swings and semis cyclicality. The implied upside to $614 requires massive multiple expansion plus sustained FCF growth, not just a one-quarter beat. The 9% 86-day yield is attractive only if you’re comfortable with being assigned at $290 or higher; much of the 'unusual' put activity could be hedging by longs or funds, not a conviction that LRCX will soar. Cautious base case seems prudent.
The spike in OTM puts may reflect hedging or risk management, not a bullish conviction; even if AI capex remains strong, a valuation re-rating is not guaranteed and downside risk could remain.
"The put volume is more likely post-Q3 hedging than bullish conviction given the FCF decline."
Claude notes the 33.6% Q/Q FCF drop but misses how that sequential weakness likely drives the Aug 21 $290 put sales as hedging by existing holders, not fresh income plays. With hyperscaler budgets already flagged for normalization by peers, any July order data could trigger assignment risk well above the $263.70 breakeven, amplifying downside if the 38% margin proves non-recurring.
"Hedging by longs doesn't prove downside; the margin sustainability question hinges on whether AI capex creates structural demand shifts, not just cyclical spikes."
Grok conflates hedging with conviction, but that's backwards. If existing holders are selling $290 puts to hedge gains, they're *protecting* upside—not signaling weakness. The 33.6% Q/Q FCF drop is real, but one quarter doesn't invalidate 38% TTM margins. The real question: is that margin structural (AI-driven fab intensity) or cyclical (temporary capex surge)? Nobody's addressed whether LRCX's customer mix has fundamentally shifted toward stickier, higher-margin relationships. That's the lynchpin.
"LRCX's margin profile is tied to narrow, volatile tech nodes rather than broad, sustainable secular growth."
Claude, you're missing the structural shift in wafer fab equipment (WFE) intensity. The 'stickiness' you mention is actually a trap; LRCX's reliance on high-bandwidth memory (HBM) and gate-all-around (GAA) logic nodes makes them hypersensitive to specific, narrow tech cycles, not broad-based demand. If those nodes hit a yield wall or if TSMC pivots capex, that 38% margin collapses. The 'income harvesting' everyone cites is just institutional exit liquidity disguised as yield.
"Margin sustainability is the real risk; if AI capex normalizes, an erosion of LRCX's 38% FCF margin could break the bull case more than hedging activity suggests."
Gemini's 'income harvesting' framing ignores a core risk: margins and demand are cyclically volatile. If AI-driven capex cools and hyperscaler budgets normalize, LRCX's 38% FCF margin is unlikely to persist, threatening a re-rating and a much lower implied FCF yield. Hedging can mask momentum, but it doesn't fix cyclicality. A break in node demand could curb cash flow and undermine the bull case.
The panel largely agrees that while LRCX's strong FCF growth and unusual put selling might suggest bullish sentiment, the cyclical nature of the semiconductor industry, potential margin compression, and customer concentration risk warrant caution. The high FCF margin may not be sustainable, and any normalization of hyperscaler budgets could lead to a re-rating of the stock.
Potential for high FCF growth if AI-driven capex continues and margins remain strong.
The cyclical nature of the semiconductor industry and potential margin compression.